Why is Hanwha Aerospace, whose target price rose 20%, still cheap? | Kwon Taek-joong, Vincent, Pyeon Da-song

목표가 20% 오른 한화에어로스페이스, 지금도 싼 이유는? | 권택중, 빈센트, 편다송 [밥 보다 투자 하나]
Watch on YouTube ↗  |  January 21, 2026 at 03:23  |  41:28  |  3PRO TV (삼프로TV)
Speakers
Kwon Taek-jung — Manager, The Centerfield W

Summary

Kwon Taek-joong, a PB at The Centerfield W, joined hosts Vincent and Pyeon Da-song to discuss the space industry, focusing on the upstream segment. He argued that cheaper launches and private-sector leadership are expanding the space economy, with satellite and antenna suppliers and Hanwha Aerospace among the clearest Korean plays. The conversation also covered memory semiconductors as the market's true leader, the KOSPI 5,000 level as a buying opportunity, and risks in biotech and obesity-drug royalties. He flagged oil, yields, and VIX as macro risk variables.

  • Upstream space includes launch vehicles, satellites, ground equipment, and related research.
  • SpaceX's lower launch costs are expanding the overall space economy.
  • Korea's rocket manufacturing base may support the domestic space industry.
  • Hanwha Aerospace is favored for defense cash flow plus space narrative.
  • Satellite and antenna suppliers have the clearest near-term revenue visibility.
  • Memory semiconductors, Samsung Electronics, and SK hynix are seen as market leaders.
  • The KOSPI correction before 5,000 is viewed as a buying opportunity.
  • Biotech and obesity-treatment royalty names face near-term headwinds.
Ideas
Kwon Taek-jung Manager, The Centerfield W 3:28
Upstream space benefits from cheaper launches.
The upstream space economy, including launch vehicles, satellites, ground equipment, and related research, is becoming more attractive because SpaceX has drastically reduced launch and orbit-insertion costs, enabling the whole space market to grow. He expects upstream to take a larger share of the space economy over time, with launch, satellite, and ground-station demand reinforcing each other.
Kwon Taek-jung Manager, The Centerfield W 17:01
Korea can become top-three space power.
Korea's rocket technology and manufacturing internalization are strong enough that it is already among major space powers. With Nuri technology transferred to Hanwha Aerospace and private-sector involvement expanding, Korea can soon reach the top three in space and rocket capability, supporting the domestic space industry.
Kwon Taek-jung Manager, The Centerfield W 17:40
Hyundai Motor has robot manufacturing edge.
Hyundai Motor can receive robot-related valuation because it already has the factories and equipment needed to manufacture robots. Its manufacturing infrastructure is a competitive advantage as robotics scales.
Kwon Taek-jung Manager, The Centerfield W 24:17
Hanwha Aerospace is preferred Korean space play.
Hanwha Aerospace is his preferred Korean space company. Its defense cash flow from K9 and Chunmoo exports remains strong, and the space narrative from Nuri technology transfer and private space leadership can justify its high valuation. He views pullbacks as opportunities, and target prices have been raised by more than 20% while he still sees it as attractive.
Kwon Taek-jung Manager, The Centerfield W 28:57
Rocket Lab is second in private launch.
Rocket Lab is the clear second-place private launch provider after SpaceX. It has rapidly followed SpaceX, increased rocket size, and is one of only two private companies with a real launch business, giving it a strong position as launch demand grows.
Kwon Taek-jung Manager, The Centerfield W 31:55
KOSPI dip before 5,000 is opportunity.
The KOSPI pullback before the symbolic 5,000 level is a risk-off and position-squaring move, not the end of the rally. He expects the index to break 5,000 and for that level to become support, so the current correction should be viewed as a buying opportunity; deleveraging could make the market healthier.
Kwon Taek-jung Manager, The Centerfield W 32:50
Memory leads and is still cheap.
Memory remains the real market leader, not space. The future growth and earnings path is already visible and is being exceeded daily, and Samsung Electronics and SK hynix are the top two. He says memory is not a bubble and is still cheap; on market drops, investors should buy memory.
Kwon Taek-jung Manager, The Centerfield W 35:01
Oil is key inflation risk to watch.
He is watching oil more than rates. Oil is rising and remains a key inflation input; if oil cannot be contained, inflation will stay sticky and pressure interest-rate expectations. That would be a risk for long-duration space and biotech stocks.
Kwon Taek-jung Manager, The Centerfield W 37:05
Korean biotech near-term unattractive.
Korean biotech is facing a combined negative from Alteogen's disappointing contract disclosure, rate sensitivity, and supply rotation into humanoid and other growth themes. Although it may eventually refill and rebound, buying the first drop is not recommended; near-term narrative is weak and approaching now is burdensome.
Kwon Taek-jung Manager, The Centerfield W 38:35
Obesity royalty economics may worsen.
Global big pharma price competition in obesity treatments is compressing drug prices. Companies that licensed out obesity assets may see future royalty streams and valuations cut because analysts value them off sales-linked royalties. The more obesity drugs become mainstream, the worse the licensing and royalty economics may become.
Up Next

This 3PRO TV (삼프로TV) video, published January 21, 2026, features Kwon Taek-jung discussing Space upstream sector, Korean space industry, 005380.KS, 012450.KS, RKLB, EWY, SMH, 005930.KS, 000660.KS, WTI, Korean biotech sector, Obesity treatment license-out companies. 10 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Kwon Taek-jung  · Tickers: Space upstream sector, Korean space industry, 005380.KS, 012450.KS, RKLB, EWY, SMH, 005930.KS, 000660.KS, WTI, Korean biotech sector, Obesity treatment license-out companies